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Abstract 
Congenital melanocytic nevus is usually defined as a melanocytic lesion which presents within 2 years of birth. 
Giant congenital melanocytic nevus (GCMN) has incidence of approximately <1:20,000 newborns. Despite being 
rare, GCMN is significant because of its association with severe complications such as malignant melanoma and 
neurocutaneous melanosis. GCMN presents as a brown lesion, with flat or mammilated surface, well-demarcated 
borders and hypertrichosis. Congenital melanocytic nevus is primarily a clinical diagnosis. Although GCMN is 
recognized as a risk factor for the development of melanoma, the precise magnitude of this risk is still controversial. 
The estimated lifetime risk of developing melanoma varies from 5 to 10%. On account of these uncertainties and the 
size of the lesions, the management of giant congenital melanocytic nevus needs individualization. Treatment may 
include surgical and non-surgical procedures, psychological intervention and/or clinical follow-up, with special 
attention to changes in color, texture or on the surface of the lesion. Indication for surgery in GCMN is the 
development of a malignant neoplasm on the lesion. 
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Introduction 
 
The global prevalence of people living with HIV has 
increased more than fourfold since 1990, reflecting 
the combined  effects of continued high rates of new 
HIV infections and the life-prolonging impact of 
antiretroviral therapy. Globally the number of AIDS 
related annual deaths have decreased by 43% since 
2003 while in eastern and southern Africa, the regions 
that are most affected by HIV, there has been a 36% 
reduction in AIDS related deaths since 2010[1]. India 
currently has an estimated 2.1 million people living 
About 1% of live births presents with a congenital 
melanocytic nevi.2 The incidence of GCMN is 
estimated at less than 1:20,000 newborns[2,3].  
GCMN occur most commonly on the posterior trunk 
or with multiple satellite lesions but may also appear 
on the head or extremities[2].Despite being rare, these 
melanocytic nevi are significant because of their 
association with with HIV(PLHIV),third highest 
globally after South Africa and Nigeria. HIV 
prevalence among adults (15-49 years) in the country 
has been declining steadily Melanocytic nevi are 
benign proliferations of melanocytic cells arranged in 
nests in the epidermis, dermis or in other tissue. Giant 
congenital melanocytic nevi (GCMN) are pigmented 
lesions seen at birth or shortly after birth[1-3]. 
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Leptomeningeal melanocytosis, major psychosocial 
impact on the patient and family, due to unsightly 
appearance and their predisposition for development of 
malignant melanoma[3,4]. 
Leptomeningeal involvement occurs most often when 
the nevus is located on the head or midline on the trunk 
and associated with multiple “satellite” melanocytic 
nevi (>20 lesions)[2,5]. Nevus cells within the 
leptomeninges and brain parenchyma can cause raised 
intracranial pressure, hydrocephalus, seizures, mental 
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retardation, and motor deficits and may result in 
melanoma. Cytological examination of the 
cerebrospinal fluid for melanin-containing cells can be 
done to screen for malignancy[6].GMN located on the 
scalp may have tendency to gradually lighten and 
regress over time[7]. Table 1 shows classification 
based on size by Kopf et al[8]. 
 
Table 1 : Classification based on Size 
Small size <2.0 cm diameter  
Intermediate size >2.0-20 cm   
Large size >20 cm  >5% of BSA 
Case Report 
35 weeks 2 days female infant (TWIN 1) born to 
Primigravida by caesarian with weight of 2280gms. 
Uneventful postnatal transit with Apgar scores 7and 8 
at 1 and 5 minutes respectively, head circumference 
33.4cm and length 47cm. Maternal serology labs 
negative with uneventful antenatal history.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1, 2: Neonate was born with melanocytic nevi 
extending from thoracic vertebrae to lower trunk 
with flat black skin lesion with smooth velvety 
appearance 
       Fig 3: multiple small satellite lesions present on 
right forearm. 
 
 
Fig 4,5: multiple small satellite lesions present on 
the bilateral lower legs, ]cheeks and on back 
          Fig 6: Neonate had 2 natal teeth at time of 
birth 
 
Neonate was born with melanocytic nevi extending 
from thoracic vertebrae to lower trunk with flat black 
skin lesion with smooth velvety appearance (Fig 1 & 2) 
and multiple small satellite lesions present on the 
bilateral lower legs, right forearm, cheeks and on back. 
(Fig 3, 4, 5) All limbs and orifices were normal. 
Neonate had 2 natal teeth at time of birth (Fig 6).                      
No neurological abnormalities noted during the 5 days 
hospital course. Cerebrospinal fluid examination was 
done and no melanin containing cells were present. 
Routine blood tests were in normal range.  
Ultrasound abdomen and Neurosonogram were normal. 
ECHO of neonate was normal. Skin biopsy was not 
done. Fundus of newborn was normal. Neonate was 
sent home and kept on follow up (1, 3, 6, 12 months of 
age) and neurological examination was normal . Skin 
biopsy was done at 1 year of age and the 
histopathological findings were consistent with those 
of congenital melanocytic naevi. No evidence of a 
malignant transformation was seen. 
Second twin was normal with no skin lesions. There 
was no family history of any similar lesion.  
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Discussion 
 
GMN develop between the 5th and 24th week of 
gestation, due to a morphological error in the 
neuroectoderm which results in dysregulated growth of 
melanoblasts. Kissing nevus, or divided nevus of the 
eyelid, divided after 20th week of gestation, implying 
GMN’s development before 20th week of 
gestation.[2,3]. 
Neural crest derived melanoblasts may be linked to the 
c-met proto-oncogene, controlling expression of the 
tyrosine kinase receptor Met[10].  Mostly affected 
individual with leptomeningeal involvement have 
associated pigmented nevi on the head, neck or dorsal 
spine area[11]. 
They may present at early age (before 2 years) with 
sign and symptoms of raised ICT, with second peak 
seen at puberty or during the adult life[12]. 
The prognosis of symptomatic patients is poor, with 
majority of these patients die within 3 years of their 
presentation of neurological symptoms, either due to 
CNS malignant melanoma or from progressive growth 
of benign melanocytic cells[13]. 
85% patients with giant congenital melanocytic nevi 
involving the head and neck have noted to have 
neurological abnormalities, although neurocutaneous 
melanosis was not detected by CT or MRI. Patients 
with neurocuatneous involvement had a posterior axial 
location of their cutaneous lesions on the head, neck, 
back and buttock[13]. 
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